The Threat of Marburg Virus Disease in West Africa: Implications for Public Health Control in Nigeria
DOI:
https://doi.org/10.60787/tnhj.v22i3.597Abstract
Marburg virus disease (MVD) is a rare but severe haemorrhagic fever caused by Marburg virus (MARV), a filamentous, non-segmented, single-stranded negative-sense RNA virus which together with Ebola virus (EBOV) are the sole members of the genus Filovirus in the family Filoviridae1. MARV was first discovered during epidemics in Marburg and Frankfurt, Germany, and in Belgrade, Serbia's capital city in 1967 and its source was traced to African green monkeys imported from Uganda2,3. Despite the significant threat that MARV poses to human and animal health, virulent and pathogenic factors are not completely understood4. All six strains of MARV (Musoke, Ratayczak, Popp, Voege, Ozolin and Marburg Ravn) are known to be highly pathogenic5. The case fatality rate (CFR) varied between 23-90% in past epidemics depending on the virus strain and early diagnosis.
Downloads
References
World Health Organization. Marburg virus disease. https://www.who.int/health-topics/marburg-virus-disease. (Accessed August 4, 2022).
Ristanovic ES, Kokoskov NS, Crozier I, Kuhn JH, Gligic AS. A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967. Microbiol Mol Biol Rev. 2020;84:e00095-19. (Accessed October 5, 2022).
Wirsiy FS, Ako-Arrey DE, Nkfusai CN, Yeika EV, Bain LE. Marburg virus disease outbreak in Guinea: a SPIN framework of its transmission and control measures for an exemplary response pattern in West Africa. Pan Afr Med J. 2021;40:143.
Abir MH, Rahman T, Das A, Etu SN, Nafiz IH, Rakib A, et al.Pathogenicity and virulence of Marburg virus. Virulence. 2022;13:609–33..
European Centre for Disease Prevention and Control. Factsheet about Marburg virus disease. https://www.ecdc.europa.eu/en/infectious-disease-topics/z-disease-list/ebola-virus-disease/facts/factsheet-about-marburg-virus (Accessed October 4, 2022).
Centers for Disease Control and Prevention. About Marburg virus disease | Marburg (Marburg Virus Disease) |. 2021. https://www.cdc.gov/vhf/marburg/about.html (Accessed August 4, 2022).
Kajihara M, Hang'ombe BM, Changula K, Harima H, Isono M, Okuya K et al. Marburgvirus in Egyptian Fruit Bats, Zambia -Emerg Infect Dis 2019; 25(8): 1577 -1580.
Mekibib B, Ariën KK. Aerosol Transmission of Filoviruses. Viruses. 2016;8(5):148. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885103/. (Accessed October 5, 2022).
Mehedi M, Groseth A, Feldmann H, Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future Virol. 2011;6(9):1091–106.
Tower JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA et al. Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola | Journal of Virology. 2006;6497-6516.
Lawrence JA, UI Rasool MH, Parikh C, Chowdhury S, Sueldo A. Emergence of Marburg Virus Disease in West Africa amid COVID-19 and Ebola: Efforts, Challenges, and Recommendations to Prevent the Next Public Health Crisis. J Infect Dis Epidemiol. 2022;8:259. doi.org/10.23937/2474-3658/1510259
World Health Organization. Marburg virus disease -Ghana. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-(Accessed August 4, 2022)
World Health Organization. Marburg virus disease -Guinea. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/marburg-virus-disease-guinea (Accessed October 3, 2022).
Centers for Disease Control and Prevention. Infectious Diseases Travel Fast and Far. 2022. Available from: https://www.cdc.gov/globalhealth/security/ghsa5year/cdc-5-years-ghsa.html (Accessed October 4, 2022).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
